Forskolin and dexamethasone synergistically induce aromatase (CYP19) expression in the human osteoblastic cell line SV-HFO

European Journal of Endocrinology

Volumn 152, Issue 4, 2005, Pages 619-624

  Watanabe, Masatada ^a   Ohno, Shuji ^a   Nakajin, Shizuo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; DEXAMETHASONE; ESTROGEN; FORSKOLIN;

ARTICLE; BONE LEVEL; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ESTROGEN THERAPY; GENE SEQUENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION;

AROMATASE; CELL LINE; DEXAMETHASONE; DRUG SYNERGISM; FORSKOLIN; GENE EXPRESSION REGULATION; HUMANS; OSTEOBLASTS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

EID: 17744387150     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01882     Document Type: Article

References (18)

1. Bilezikian JP, Morishima A, Bell J & Grumbach MM. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. New England Journal of Medicine 1998 339 599-603.
2. Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, Korach KS & Simpson ER. Effect of testosterone and estradiol in a man with aromatase deficiency. New England Journal of Medicine 1997 337 91-95.
3. Maffei L, Murata Y, Rochira V, Tubert G, Aranda C, Vazquez M, Clyne CD, Davis S, Simpson ER & Carani C. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. Journal of Clinical Endocrinology and Metabolism 2004 89 61-70.
4. Morishima A, Grumbach MM, Simpson ER, Fisher C & Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. Journal of Clinical Endocrinology and Metabolism 1995 80 3689-3698.
5. Sasano H, Uzuki M, Sawai T, Nagura H, Matsunaga G, Kashimoto O & Harada N. Aromatase in human bone tissue. J Bone Mineral Research 1997 12 1416-1423.
6. Masi L, Becherini L, Gennari L, Amedei A, Colli E, Falchetti A, Farci M, Silvestri S, Gonnelli S & Brandi ML. Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk. Journal of Clinical Endocrinology and Metabolism 2001 86 2263-2269.
7. Nawata H, Tanaka S, Takayanagi R, Sakai Y, Yanase T, Ikuyama S & Haji M. Aromatase in bone cell: association with osteoporosis in postmenopausal women. Journal of Steroid Biochemistry and Molecular Biology 1995 53 165-174.
8. Shozu M & Simpson ER. Aromatase expression of human osteoblast-like cells. Molecular and Cellular Endocrinology 1998 139 117-129.
9. Sasano H & Harada N. Intratumoral aromatase in human breast, endometrial, and ovarian malignancies. Endocrine Reviews 1998 19 593-607.
10. Sebastian S & Bulun SE. A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the Human Genome Project. Journal of Clinical Endocrinology and Metabolism 2001 86 4600-4602.
11. Simpson ER, Zhao Y, Agarwal VR, Michael MD, Bulun SE, Hinshelwood MM, Graham-Lorence S, Sun T, Fisher CR, Qin K & Mendelson CR. Aromatase expression in health and disease. Recent Progress in Hormone Research 1997 52 185-213 discussion 213-214.
12. Watanabe M, Simpson ER, Pathirage N, Nakajin S & Clyne CD. Aromatase expression in the human fetal osteoblastic cell line SV-HFO. Journal of Molecular Endocrinology 2004 32 533-545.
13. Chiba H, Sawada N, Ono T, Ishii S & Mori M. Establishment and characterization of a simian virus 40-immortalized osteoblastic cell line from normal human bone. Japanese Journal of Cancer Research 1993 84 290-297.
14. Janssen JM, Bland R, Hewison M, Coughtrie MW, Sharp S, Arts J, Pols HA & van Leeuwen JP. Estradiol formation by human osteoblasts via multiple pathways: relation with osteoblast function. Journal of Cell Biochemistry 1999 75 528-537.
15. Watanabe M & Nakajin S. Forskolin up-regulates aromatase (CYP19) activity and gene transcripts in the human adrenocortical carcinoma cell line H295R. Journal of Endocrinology 2004 180 125-133.
16. Penuelas I, Encio IJ, Lopez-Moratalla N & Santiago E. cAMP activates transcription of the human glucocorticoid receptor gene promoter. Journal of Steroid Biochemistry and Molecular Biology 1998 67 89-94.
17. Christoffels VM, Grange T, Kaestner KH, Cole TJ, Darlington GJ, Croniger CM & Lamers WH. Glucocorticoid receptor, C/EBP, HNF3, and protein kinase A coordinately activate the glucocorticoid response unit of the carbamoylphosphate synthetase I gene. Molecular and Cellular Biology 1998 18 6305-6315.
18. Sato A, Sheppard KE, Fullerton MJ & Funder JW. cAMP modulates glucocorticoid-induced protein accumulation and glucocorticoid receptor in cardiomyocytes. American Journal of Physiology Endocrinology and Metabolism 1996 271 E827-E833.